Interest-bearing debt
Pass0.0%of market cap
0%limit 30%
Filed balance sheet (Form 10-Q, period ending 2026-06-30): no borrowings; every liability line is accounted for
PCVXNasdaq
Technology · Biotechnology
Verdict
No verdict: a figure the screen needs is missing from the company's filings.
AAOIFI Shari'ah Standard No. 21 · not certified · screened 17 Oct 2026
Each bar shows the figure against its limit; the line marks the limit.
0.0%of market cap
Filed balance sheet (Form 10-Q, period ending 2026-06-30): no borrowings; every liability line is accounted for
15%of market cap
Filed financial statements
—of revenue
No current twelve-month interest-income figure in the company's filings.
No prohibited activity (alcohol, gambling, tobacco, conventional finance, pork, adult content) found in the sector, SEC industry or company name.
See the business + financial screening, dividend purification ratio, and category-by-category compliance status.
Upgrade to Pro